Background: Dihydrotestosterone (DHT) induces androgenic alopecia by shortening the hair follicle growth phase, resulting in hair loss. We previously demonstrated how changes in the microRNA (miRNA) expression profile influenced DHT-mediated cell death, cell cycle arrest, cell viability, the generation of reactive oxygen species (ROS), and senescence. Protective effects against DHT have not, however, been elucidated at the genome level. Objective: We showed that epigallocatechin gallate (EGCG), a major component of green tea, protects DHT-induced cell death by regulating the cellular miRNA expression profile. Methods: We used a miRNA microarray to identify miRNA expression levels in human dermal papilla cells (DPCs). We investigated whether the miRNA expression influenced the protective effects of EGCG against DHT-induced cell death, growth arrest, intracellular ROS levels, and senescence. Results: EGCG protected against the effects of DHT by altering the miRNA expression profile in human DPCs. In addition, EGCG attenuated DHT-mediated cell death and growth arrest and decreased intracellular ROS levels and senescence.
INTRODUCTION
Androgenic alopecia causes hair loss by shortening the growth phase (anagen) of hair follicles; it is provoked by excessive androgen-receptor activation by androgens such as testosterone and dihydrotestosterone (DHT) in post-pubertal males [1] [2] [3] . Androgen-induced regulation of the hair growth cycle results in early growth cessation (catagen) 4 .
Specifically, DHT produced by 5α-reductase strongly activates the androgen receptors, because its binding affinity is two to three times that of testosterone 5, 6 . The activity or expression of 5α-reductase is elevated in most cases of androgenic alopecia 7 . Therefore, 5α-reductase and androgen receptors are attractive therapeutic targets for that condition 8, 9 . The DHT-mediated activation of androgen receptors induces the expression of various downstream genes that are related to hair follicle development, morphology, and cell cycling 10, 11 .
In a recent study, DHT was shown to regulate microRNAs (miRNAs) in dermal papilla cells (DPCs), a group of specialized fibroblasts within the hair follicle bulb 12 . Additionally, miRNAs exhibit altered expression profiles in the balding dermal papilla 13 . miRNAs are small, non-coding RNAs containing 19∼24 nucleotides. They target specific sequences within messenger RNAs (mRNAs) and repress mRNA translation, thus playing important roles in the development, cell cycle regulation, apoptosis, differentiation, and cell proliferation [12] [13] [14] .
Epigallocatechin gallate (EGCG), a representative ingredient in green tea, is a major polyphenolic constituent used widely for its anti-cancer effects, protection against ultraviolet light-induced DNA damage, and antioxidant and anti-inflammation activities [15] [16] [17] [18] [19] [20] . In hair follicles, EGCG prevents androgenic alopecia by inhibiting 5α-reductase activity 21 . EGCG promotes hair growth by activating Erk and Akt signaling and increasing the B-cell lymphoma 2 (BCL2)/Bax ratio in DPCs 22 . Additionally, it has been reported that EGCG protects against ultraviolet light-mediated cell death and cell cycle arrest by regulating specific miRNAs 23 . Here, we demonstrate that EGCG protects against DHT-induced cell death, cell cycle arrest, senescence, and oxidative stress in human DPCs by inducing changes in the miRNA expression profile.
MATERIALS AND METHODS
Chemicals and cell culture EGCG and DHT were purchased from Sigma-Aldrich (St. Louis, MO, USA). Human DPCs (Innoprot, Biscay, Spain), characterized and isolated from the frontal head region of a non-balding male 34 years of age, were maintained in Dulbecco's minimal essential medium (DMEM; Gibco/Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 100 IU/ml penicillin, and 100 μg/ml streptomycin. The cultures were incubated at 37 o C in a humidified atmosphere of 5% CO2.
Cell viability assay
Human DPCs were seeded in 96-well plates (5×10 3 cells per well) in triplicate. After 24 hours, the cells were exposed to the indicated concentrations of DHT and EGCG.
To assess the cell viability, the cells were incubated in a water soluble tetrazolium salt (WST-1) solution for 30 minutes, and the optical density at 490 nm was subsequently measured.
Cell cycle analysis Total RNA extraction and miRNA expression profile Total cellular RNA was isolated with TRIzol reagent (Invitrogen/Life Technologies, Grand Island, NY, USA) according to the manufacturer's instructions. miRNA labeling, hybridization, and microarray analyses were performed as described previously 24 . The isolated RNAs were labeled with Cy3 using the Agilent miRNA labeling kit (Agilent Technologies, Santa Clara, CA, USA). The labeled RNAs were purified using Micro Bio-Spin P-6 columns (Bio-Rad Laboratories, Hercules, CA, USA). For the miRNA expression profile, the SurePrint G3 Human V16 miRNA 8×60 K array (Agilent Technologies), including 1205 annotated miRNA sequences, was hybridized with the labeled total cellular RNA at 65 o C for 20 hours. The microarray was scanned using an Agilent Microarray Scanner (Agilent Technologies), and the images were analyzed using the Agilent Feature Extraction Software (Agilent Technologies). A signal analysis of the microarrays (GeneSpring GX ver. 11.5, Agilent Technologies) compared the fluorescence intensities between samples obtained from control and EGCG-treated human DPCs, respectively.
Bioinformatics analysis and target prediction
The PITA (http://genie.weizmann.ac.il), microRNAorg (http:// www.microrna.org), and TargetScan (http://www.targetscan. org) online software programs were used for bioinformatics analysis and miRNA target prediction. The gene ontologies (GOs) of the putative target genes were analyzed using the Database for Annotation, Visualization, and Integrated Discovery Bioinformatics Resource 6.7 (http:// david.abcc.ncifcrf.gov).
Statistical analysis
The data are presented as the mean±standard deviation. Statistical significance was calculated using Student's two-tailed t-test, and p＜0.01 was considered statistically significant unless otherwise indicated.
RESULTS EGCG attenuated DHT-induced growth arrest in human DPCs
To determine the effect of EGCG on the cytotoxicity of DHT in human DPCs, we performed cell viability assays. M dihydrotestosterone (DHT). To detect intracellular ROS levels, we performed 2',7'-dichlorofluorescein diacetate staining and detected cell cycle changes using a FACScalibur flow cytometer (BD Biosciences, San Jose, CA, USA). Changes in intracellular ROS levels were determined with the M1 gate. (B) Cells were treated with 10 μM EGCG or 10 −4 M DHT for 48 hours. Senescence was measured using senescence-associated β-gal assays. Senescence data are expressed as percentages of the senescence of the internal control (untreated sample) and are shown as the mean±standard error of the mean of three independent experiments. PI: propidium iodide (SigmaAldrich, St. Louis, MO, USA). The cell viability increased with 10 μM EGCG, but it decreased with EGCG concentrations ≥20 μM (Fig. 1A) . That result corroborates a previous finding that EGCG has concentration-dependent dual functions 25 . Next, we investigated whether EGCG protected against DHT-induced growth arrest. EGCG (0∼15 μM) attenuated DHT-induced growth arrest in the human DPCs in a dose-dependent manner (Fig. 1B) . All three of the EGCG doses tested produced significant protective effects. In addition, EGCG decreased levels of DHT-mediated cell death (Fig. 1C) .
Overall, DHT decreased cell viability, but the EGCG treatments rescued the DHT-mediated decrease in cell viability by repressing cell death.
EGCG ameliorated DHT-induced reactive oxygen species levels and senescence in human DPCs EGCG ameliorated the DHT-mediated elevation of intracellular reactive oxygen species (ROS) levels ( Fig. 2A) .
Because intracellular ROSs are involved in inducing senescence 11 , we investigated whether EGCG inhibited senescence in human DPCs by quantifying the activity of senescence-associated β-gal. As shown in Fig. 2B , EGCG significantly inhibited DHT-induced senescence.
EGCG altered miRNA expression profiles in DHT-treated human DPCs
Finally, we assessed whether EGCG altered miRNA expression profiles in DHT-treated human DPCs. Recent studies have shown that EGCG is a natural regulator of miRNAs that can influence cell growth, apoptosis, and cell cycle regulation. Among the 1205 annotated miRNAs analyzed, 13 miRNAs showed up-regulation by more than twofold, and 40 miRNAs showed down-regulation by more than twofold after EGCG administration to DHTtreated human DPCs (Table 1) . Using three bioinformatics and target prediction systems, we identified target genes of 54 miRNAs that were up-regulated or down-regulated by the EGCG treatment in DHTtreated human DPCs (Table 2) . Overall, we analyzed 306 putative target genes of 13 up-regulated miRNAs and 134 putative target genes of 40 down-regulated miRNAs. Next, we identified the biological roles of the putative target genes by GO analysis. The putative target genes were classified into five major functional categories: anti-oxidation, apoptosis and cell death, proliferation and cell growth, aging, and cell cycle-related (Fig. 3) . The protective effects of EGCG against DHT-mediated growth arrest, cell death, increased ROS, and senescence were strongly associated with the altered miRNA expression profile.
DISCUSSION
In the present study, we showed the biological effects of EGCG and EGCG-mediated changes in miRNA profiles in DHT-exposed human DPCs. EGCG is a well-known, dual-role agent that protects against cellular damage in impaired cells and also induces cell death in various tumors [26] [27] [28] [29] [30] [31] . We investigated whether EGCG reduced DHTmediated cellular damage in human DPCs. The results shown in Figs. 1 and 2 suggest that EGCG inhibits DHT-induced cell death, intracellular ROS levels, and senescence. In general, DHT increases intracellular ROS levels, which induce cell death and growth arrest 32, 33 .
EGCG, a powerful antioxidant, ameliorated the DHTmediated elevation of intracellular ROS levels and thus protected the human DPCs 17 . EGCG treatment alone slightly increased the sub-G1 cell population, however, which suggests that EGCG induced some cell death under normal conditions (Fig. 1C) . Several previous studies have shown that high concentrations of EGCG induce cell death and cell cycle arrest in various cancers [28] [29] [30] [31] . Lu et al. 34 showed that EGCG can induce cell death at low concentrations (＜100 μM) in normal human lung and skin cells, because antioxidants such as EGCG eliminate intercellular ROSs used as signal molecules 34, 35 . Thus, low concentrations of EGCG can induce some degree of cell death under normal conditions. We showed the effects of EGCG on the miRNA profile in DHT-exposed human DPCs. EGCG significantly up-regulated or down-regulated 53 miRNAs. Previous studies have identified direct target genes and physiological roles in some of those miRNAs. Hsa-miR-210 (330.95-fold increase) promotes proliferation and represses growth arrest through the targeting of fibroblast growth factor receptorlike 1 (FGFRL1), apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3), stathmin (STMN1), probable dimethyladenosine transferase (DIMT1), protein tyrosine phosphatase non-receptor type 2 (PTPN2), and iron-sulfur cluster scaffold homolog 2 (ISCU2) [36] [37] [38] [39] . Hsa-miR-590-5p
(147.55-fold increase) promotes cell growth and survival by targeting the S100 calcium-binding protein A10 (S100A10), transforming growth factor beta receptor II (TGF-β RII), and close homolog of L1 (CHL1) [40] [41] [42] . The overexpression of hsa-miR-370 (2.22-fold increase) in-duces proliferation by interfering with forkhead box protein O1 (FOXO1) 43, 44 . Hsa-miR-188-5p (147.60-fold decrease) suppresses the G1/S transition by targeting cyclin D1 (CCND1), CCND3, CCNE2, CCNA2, cyclin-dependent kinase 4 (CDK4), and CDK2 45 . Hsa-miR-28-5p (49.61-fold decrease) targets MAD2 mitotic arrest deficient-like 1 (MAD2L1), BCL2-associated athanogene (BAG1), and the rat sarcoma viral oncogene homolog (RAS) oncogene family (RAP1B and RAB23) 46 , which can regulate cell proliferation, migration, and invasion by influencing spindle checkpoint control, apoptosis, and GTPase-mediated signal transduction. Furthermore, we predicted the targets of a number of the EGCG-regulated miRNAs using Targetscan, PITA, and microRNAorg ( Table 2 ). Many of the predicted target genes are associated with pathways regulating anti-oxidation, apoptosis and cell death, proliferation and cell growth, aging, and the cell cycle (Fig. 3) . Our results show that the EGCG-mediated regulation of those regulatory pathways is related to alterations of miRNA expression in DHT-exposed human DPCs. Overall, our investigation revealed EGCG-mediated changes in miRNA expression that protect against the DHT-induced human DPC phenotype. Our microarray analyses show that EGCG modulates the expression of miRNAs involved in oxidation, apoptosis and cell death, proliferation and cell growth, aging, and the cell cycle, providing an overall protective effect against DHT.
